Petrelli Alessio, Giorgi Rossi Paolo, Francovich Lisa, Giordani Barbara, Di Napoli Anteo, Zappa Marco, Mirisola Concetta, Gargiulo Lidia
Epidemiology Unit, National Institute for Health, Migration and Poverty (INMP), Rome, Italy.
Epidemiology Unit, AUSL Reggio Emilia, Reggio Emilia, Italy.
BMJ Open. 2018 Sep 19;8(9):e021653. doi: 10.1136/bmjopen-2018-021653.
The Italian National Health Service instituted cervical and breast cancer screening programmes in 1999; the local health authorities have a mandate to implement these screening programmes by inviting all women aged 25-64 years for a Pap test every 3 years (or for an Human Papilloma Virus (HPV) test every 5 years) and women aged 50-69 years for a mammography every 2 years. However, the implementation of screening programmes throughout the country is still incomplete. This study aims to: (1) describe cervical and breast cancer screening uptake and (2) evaluate geographical and individual socioeconomic difference in screening uptake.
Data both from the Italian National Health Interview Survey (NHIS) conducted by the National Institute of Statistics in 2012-2013 and from the Italian National Centre for Screening Monitoring (INCSM) were used. The NHIS interviewed a national representative random sample of 32 831 women aged 25-64 years and of 16 459 women aged 50-69 years. Logistic multilevel models were used to estimate the effect of socioeconomic variables and behavioural factors (level 1) on screening uptake. Data on screening invitation coverage at the regional level, taken from INCSM, were used as ecological (level 2) covariates.
Total 3-year Pap test and 2-year mammography uptake were 62.1% and 56.4%, respectively; screening programmes accounted for 1/3 and 1/2 of total test uptake, respectively. Strong geographical differences were observed. Uptake was associated with high educational levels, healthy behaviours, being a former smoker and being Italian versus foreign national. Differences in uptake between Italian regions were mostly explained by the invitation coverage to screening programmes.
The uptake of both screening programmes in Italy is still under acceptable levels. Screening programme implementation has the potential to reduce the health inequalities gap between regions but only if uptake increases.
意大利国家医疗服务体系于1999年设立了宫颈癌和乳腺癌筛查项目;地方卫生当局有责任通过每3年邀请所有25 - 64岁女性进行一次巴氏试验(或每5年进行一次人乳头瘤病毒(HPV)检测)以及每2年邀请50 - 69岁女性进行一次乳房X光检查来实施这些筛查项目。然而,全国范围内筛查项目的实施仍不完整。本研究旨在:(1)描述宫颈癌和乳腺癌筛查的接受情况;(2)评估筛查接受情况在地理和个体社会经济方面的差异。
使用了来自意大利国家统计局在2012 - 2013年进行的意大利国家健康访谈调查(NHIS)以及意大利国家筛查监测中心(INCSM)的数据。NHIS对32831名25 - 64岁女性和16459名50 - 69岁女性进行了全国代表性随机抽样访谈。使用逻辑多水平模型来估计社会经济变量和行为因素(第1级)对筛查接受情况的影响。从INCSM获取的区域层面筛查邀请覆盖率数据被用作生态(第2级)协变量。
3年巴氏试验和2年乳房X光检查的总体接受率分别为62.1%和56.4%;筛查项目分别占总检测接受率的1/3和1/2。观察到明显的地理差异。接受情况与高教育水平、健康行为、曾经吸烟以及意大利籍而非外国国籍相关。意大利各地区接受情况的差异大多由筛查项目的邀请覆盖率来解释。
意大利这两项筛查项目的接受率仍处于可接受水平之下。筛查项目的实施有潜力缩小各地区之间的健康不平等差距,但前提是接受率要提高。